Curative Biotechnology (Curative Biotechnology) Interest Expense : $-1.37 Mil (TTM As of Mar. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Curative Biotechnology Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Curative Biotechnology's interest expense for the three months ended in Mar. 2023 was $ -0.31 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2023 was $-1.37 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Curative Biotechnology's Operating Income for the three months ended in Mar. 2023 was $ -0.66 Mil. Curative Biotechnology's Interest Expense for the three months ended in Mar. 2023 was $ -0.31 Mil. Curative Biotechnology did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Curative Biotechnology Interest Expense Historical Data

The historical data trend for Curative Biotechnology's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biotechnology Interest Expense Chart

Curative Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.02

-0.04

-0.18

-1.17

Curative Biotechnology Quarterly Data
	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Interest Expense	Get a 7-Day Free Trial															-0.11	-0.32	-0.34	-0.40	-0.31

Curative Biotechnology Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.37 Mil.

Curative Biotechnology (OTCPK:CUBT) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Curative Biotechnology's Interest Expense for the three months ended in Mar. 2023 was $-0.31 Mil. Its Operating Income for the three months ended in Mar. 2023 was $-0.66 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2023 was $0.00 Mil.

Curative Biotechnology's Interest Coverage for the quarter that ended in Mar. 2023 is calculated as

Curative Biotechnology did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Curative Biotechnology (Curative Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curative Biotechnology Inc (OTCPK:CUBT) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1825 NW Corporate Boulevard, Suite 110, Boca Raton, FL, USA, 33431

Website

https://www.curativebiotech.com

Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The company currently has ongoing programs in three therapeutic areas: Infectious Disease, Neuro-Oncology, and Degenerative Eye Disease.